International Severe Acute Respiratory Infection Consortium (ISARIC) (360G-Wellcome-098091_Z_12_Z)
It has become increasingly recognized from a series of recent outbreaks of emerging pathogens of global public health importance that mounting clinical research in response toa rapidly emerging infectious disease is extremely challenging, often delayed and of increasing importance. The Consortium will establish a new paradigm for collaborative clinical research in rapidly emerging public health threats with a focus on severe acute respiratory infections. We will do this with the open access development and implementation of inter-pandemic research studies, pre-approval of protocols for future epidemics, and with a new approach to bioethics in emergent events, communication and data and sample sharing. This will be matched by ensuring there is equitable sharing in the benefits of the research. If successful, we hope that this would become an indispensible component of the global research landscape and be a framework for research in rapidly emerging public health threats. The Consortium will be overseen by a Governing Board with an Executive Committee of investigators who will be responsible for the leadership and development of the mission, goals, and objectives of the Consortium. A Secretariat, based in the Nuffield Department of Medicine Oxford University and linking with regional hubs currently proposed for Mexico, Canada, Bangladesh, and Singapore, although others will be added in future, will implement the objectives of the Consortium. We would welcome your advice on membership of the Governing Board, which we propose should be led by an internationally recognized chair and vice-chair from the scientific and/or public health communities and which will bring together global partners interested in changing our research approach to rapidly emerging public health threats.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 125000 |
Applicant Surname | Farrar |
Approval Committee | ERG5 Pathogen Biology and Disease Transmission |
Award Date | 2011-11-30T00:00:00+00:00 |
Financial Year | 2011/12 |
Grant Programme: Title | Discretionary Award – Science |
Internal ID | 098091/Z/12/Z |
Lead Applicant | Dr Jeremy Farrar |
Partnership Value | 125000 |
Planned Dates: End Date | 2013-09-30T00:00:00+00:00 |
Planned Dates: Start Date | 2012-01-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | South East |